chr1-161629930-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_001244753.2(FCGR3B):āc.167A>Gā(p.Asn56Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000113 in 1,411,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001244753.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCGR3B | NM_001244753.2 | c.167A>G | p.Asn56Ser | missense_variant | 3/5 | ENST00000650385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCGR3B | ENST00000650385.1 | c.167A>G | p.Asn56Ser | missense_variant | 3/5 | NM_001244753.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 107682Hom.: 0 Cov.: 16 FAILED QC
GnomAD3 exomes AF: 0.00000404 AC: 1AN: 247324Hom.: 0 AF XY: 0.00000747 AC XY: 1AN XY: 133922
GnomAD4 exome AF: 0.0000113 AC: 16AN: 1411026Hom.: 0 Cov.: 34 AF XY: 0.00000713 AC XY: 5AN XY: 700904
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 107682Hom.: 0 Cov.: 16 AF XY: 0.00 AC XY: 0AN XY: 51342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.167A>G (p.N56S) alteration is located in exon 4 (coding exon 3) of the FCGR3B gene. This alteration results from a A to G substitution at nucleotide position 167, causing the asparagine (N) at amino acid position 56 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at